George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Possible fund raise? Nailed on probable given that Adams has a history of stiffing shareholders as you know over the last 5/6 years. I'm surprised that s/p is holding up as well as it is. when still no sign of any cash in bank after years of promises. Currently TK is just a plan on paper -no resttlement, no mine built, no gold etc extracted.....shameful frankly
Bundred is not the man to chair this company as what is needed is some honest conversations and self-examination, and that is clearly not going to happen while he is chair supposedly overseeing strategy, holding KJ and Maddicks to account and properly representing owners' (i.e. shareholders ) interests.
Too bloody right! If I were Richard sneller, I'd be on the phone to our useless chairman demanding an explanation.
Another lousy display of leadership from Bundred & Johnson, who continue to prove (a) their complete lack of understanding about how the public markets operate and their complete disregard for their own investors. This Tau was hugely important in setting the right tone and restoring some faith in the management and board. It did neither! Bundred has to Look, once again operationally one can’t believe a word they say!
In the teeth of an existential crisis that entailed investors bailing out the company, Bundred & Johnson went on record repeatedly stating they were on target to hit £8.3m YE, blustering about Oct being best month ever at £1m.
Come today’s TU, they miss that target & give no apology or explanation, leaving us all wondering whether any forecasts they make can be trusted. Whilst 300k in lost production is small vs potential, it is the principal that is at stake here with 2 individuals who clearly just make stuff up!
If they can’t get these forecasting right god help us when we get to £75m potential capacity So they basically flat lined into year end, blithely missing their own target, waved 2 fingers at s/holders in the process .
As of that’s not enough, then there’s the weasly PR spinners wording around “No new technical problems have arisen in recent months ”, effectively signalling that existing technical problems persist as do “ potential points of failure” Johnson and new FD need to be hauled over the coals for this ….not good enough!!!!
Bottom line - despite all the s*** Bundred &Johnon have put s/holders thro in last 18 mnths they still cant to be trusted and that is why in the absence of any evidence eto the contrary, the share price will continue to languish.
Just an obsessive chartist is our Zak…will be delighted if the tea leaves are accurate as will be part way to recouping the accumulated losses sustained under Newland and Griffiths. However I treat everything Mir produces ( like that other punter Winnifrith) with a salt mountain. After all wtf does he know about the fundamentals, the management, the tech, the history….
Am cautious, and carry the battle scars of Newland’s leadership like many long term holders. Newland needs a steady stream of announcements to show that after 10 years this is finally a grown up company with a grown up management capable of delivering on the multiple promises made over that time. One concern always with Newland and Griffiths is that they are shoving out announcements just to tee a/holders up for another hugely dilutive fund raising. They claim Q2/3 next year but with their track record, don’t be surprised if it happens much sooner
A welcome development but with Nero’s hyping ability everything should be put in context! SP reaction takes the share price merely back to where it was in September , so hardly rocket-fuelled, and still half of what it was 12 months ago before the realisation that Newland wasn’t getting commercial contracts across the line etc….
Adams continues to string folks along I see helped by Winnifrith that doyenne of penny stock tips. The chances of this going ahead without Adams again stuffing s/holders Q1 24 have thought is close to zero given his abysmal track record. But happy to be stand corrected
You are absolutely correct BUT once again we have Newland/Griffiths on the one hand hyping the deal, and on the other hand not explaining what the timescale is for the Phase II nor when the $250,000 revenue can be recognised. They continue to behave as if all their investors are idiots, by seemingly deliberately refusing to link deals like this to their revenue outlook! Just so typical of the two of them (no wonder Jefferies got fed up)!
Just go back to the Nov 9 Trading Update. and remember this is a December YE so should be reasonably easy to fo Newland stated that:
"New sales secured in 2023 are expected to be c. £3.3 million however revenue recognition for some of these sales will fall into the 2024 financial year. "
Question 1: Is the Eisai contract a new sale secured in 2023 whose revenue will fall into 2024 FY? Seems that it is so why not bloody confirm this and confirm that the revenue will be recogbnised this year....
If you recall Newland banged on about about
I mean seriously $250k pilot study - is this the deal that AN was desperately touting to Yankee investors! No wonder sp has not responded....
Fingers crossed....expect no follow through from director purchases
Sensible review of CPI. I purchased a slug c18p and have been adding slowly as I felt pretty much all the remedial work had been done and the new CEO is coming on-board with most of the repair work completed. However, whilst the positives outweigh the negatives, a degree of caution is required here - new CEO strategy; weak economic background; over optimism on pace of interest rate reductions; Politics...Labour's view on outsourcing etc....
So is the significant large pharma contract Nero was punting ? If so it’s another case of ludicrous hype from Newland. Yes Eisai is a recognised major pharma name, and yes it is strong validation of parsortix, but and it’s a big but, this hardly validates the commercial case does it? The value of the contract if this is the big one is miniscule: $250,000 is barely going to move the dial for a company burning thro £20m a year. And by revealing the value finally, it gives context to just how tiny the value of previous deals AGL announced but didn’t put a £ next to. It is a good start to the year but Newland is going to have to produce plenty of these types of deals to get the share price back to the mid 30s where it was 12 months ago!
It would be great if NEWLAND’s New Year’s resolution was to keep his mouth shut and stop single handedly destroying share price with ludicrous front-running predictions on toe-ups and results that then don’t materialise!
Bonkers not boners*
Nov 9th Trading Update . Begs the question, why make yourself a hostage to fortune by making this comment? Boners, no one forced them to include such an explicit expectation in the update. So unless s/thing gets done over Xmas, another missed milestone from Newland.
"The extension of our molecular capability across multiple molecular platforms will also support product sales to the customers of the installed base of these molecular platforms as it will drive the generation of a stream of clinical evidence of the value of such analysis, THE FIRST OF WHICH WE EXPECT TO PUBLISH BEFORE THE YEAR END"
Am trying to encourage other shareholders who cant be happy with the way Newland has managed this to voice their grievances. Are you invested, if so then join the chorus?
SO pleased that my moniker for Newland has gained other advocates....his ability to 'fiddle while the company's shareholders burn remains unsurpassed. I am not surprised that Jeffereies walked away after his puffery at the OTC US investors proved the final straw. Listen to what he says - incredible that he cannot control his tongue......
What choice did he have, given Bundred and Johnson took a sledge hammer to the share price. Extraordinarily neither has seen fit to apologise, and Bundred should just leave before he does any more damage as his credibility is shot to pieces and he is a laughing stock
All of the shareholders that Newland has so comprehensively shafted would love to believe you're correct, but as per 2H 2022, throughout FY 2023 Nero has continued his one-man wrecking ball crusade, and the year isn't yet over, so still more room for disappointment (check out his comments to US OTC investors the other week)!. If only one could believe 2024 will be different!